Emergent BioSolutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	160.3	205.4	99.5	111.7	642.6	576.1
Cash & Short-Term Investments	160.3	205.4	99.5	111.7	642.6	576.1
Cash Growth	7.51%	106.43%	-10.92%	-82.62%	11.54%	-7.27%
Accounts Receivable	121.6	84.2	154.5	191	159.2	278.9
Inventory	327.6	343.4	311.7	328.9	350.7	344.5
Other Current Assets	28.1	29.5	33	47.9	57.9	70.4
Total Current Assets	637.6	662.5	598.7	679.5	1,210	1,270
Net Property, Plant & Equipment	199.4	205.4	270.6	382.8	817.6	800.1
Other Intangible Assets	470.4	436.5	501.5	566.6	728.8	604.6
Goodwill	-	-	-	-	218.2	224.9
Other Long-Term Assets	13	14.2	18.9	194.3	191.3	58.2
Total Assets	1,320	1,319	1,390	1,823	3,166	2,958
Accounts Payable	39.5	55.6	60.9	112.2	103.5	128.9
Accrued Expenses	38.6	60.8	73.8	92.7	122.2	140.4
Short-Term Debt	-	-	-	413.7	957.3	31.6
Current Portion of Long-Term Debt	-	-	-	413.7	957.3	31.6
Unearned Revenue	12.2	5	-	-	-	-
Other Current Liabilities	58.4	10.8	27.7	32.7	45.9	73.1
Total Current Liabilities	148.7	132.2	162.4	651.3	1,229	374
Long-Term Debt	573.6	572.1	663.7	446.5	448.5	809.4
Other Long-Term Liabilities	75	91.7	80.8	76.1	101.2	162.8
Total Long-Term Liabilities	648.6	663.8	744.5	522.6	549.7	972.2
Total Liabilities	797.3	796	906.9	1,174	1,779	1,346
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Treasury Stock	-261.6	-252.6	-227.7	-227.7	-227.7	-152.2
Additional Paid-in Capital	944.5	942.4	928	904.4	873.5	829.4
Accumulated Other Comprehensive Income	-6.9	-7.5	-5.2	-5.7	3.1	-16.1
Retained Earnings	-153	-159.8	-212.4	-21.8	738.7	950.3
Shareholders' Equity	523.1	522.6	482.8	649.3	1,388	1,612
Total Liabilities & Equity	1,320	1,319	1,390	1,823	3,166	2,958
Total Debt	573.6	572.1	663.7	1,274	2,363	872.6
Net Cash (Debt)	-413.3	-366.7	-564.2	-1,162	-1,721	-296.5
Net Cash Per Share	-7.53	-6.47	-10.64	-22.70	-34.34	-5.48
Book Value	523.1	522.6	482.8	649.3	1,388	1,612
Book Value Per Share	9.53	9.22	9.11	12.68	27.70	29.79
Tangible Book Value	52.7	86.1	-18.7	82.7	440.7	782
Tangible Book Value Per Share	0.96	1.52	-0.35	1.62	8.80	14.45

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q